European Academy of Neurology (EAN) Congress 2024

Helsinki, Finland 29 June 2024 - 02 July 2024

Galcanezumab a safer choice than prednisone for medication overuse headache

26 Jul 2024 by

Both galcanezumab and prednisone effectively relieve pain in people with medication overuse headache (MOH), with combination therapy using both medications yielding the greatest benefit, according to the results of a three-arm, head-to-head observational study. However, the use of prednisone is accompanied by an increased frequency of adverse events.

Galcanezumab a safer choice than prednisone for medication overuse headache

26 Jul 2024

Meta-analysis strengthens case for argatroban use in patients with END after stroke

24 Jul 2024 by

Argatroban appears to reduce neurological deficits in acute ischaemic stroke (AIS) patients with early neurological deterioration (END) who are undergoing thrombolytic therapy, without increasing the risk of symptomatic intracranial haemorrhage, according to the results of a meta-analysis.

Meta-analysis strengthens case for argatroban use in patients with END after stroke

24 Jul 2024

Is there a link between parental smoking, MS?

24 Jul 2024 by

A study presented at EAN 2024 found that selective exposure to parental smoking at an early age may increase the risk of developing multiple sclerosis (MS) later in life.

Is there a link between parental smoking, MS?

24 Jul 2024

Nipocalimab + SoC improves MG-ADL scores in adults with myasthenia gravis

23 Jul 2024 by

Adding nipocalimab to standard-of-care (SoC) treatment significantly improves Myasthenia Gravis-Activities of Daily Living (MG-ADL) scores in patients with generalized MG (gMG), according to the pivotal phase III Vivacity-MG3 study presented at EAN 2024.

Nipocalimab + SoC improves MG-ADL scores in adults with myasthenia gravis

23 Jul 2024

Are bad dreams tied to cognitive decline, dementia in adults?

22 Jul 2024 by

Having frequent distressing dreams may signal a higher risk of developing cognitive decline and dementia in adults, according to a prospective study of three population-based cohorts.

Are bad dreams tied to cognitive decline, dementia in adults?

22 Jul 2024

Omaveloxolone slows neurological progression in earlier-onset Friedreich’s ataxia

22 Jul 2024 by

The treatment effect of omaveloxolone in halting progression, based on change in mFARS score, is particularly pronounced in individuals with Friedreich's ataxia who had disease onset at ≤15 years of age, suggests a post hoc subgroup analysis of MOXIe Part 2 presented at EAN 2024.

Omaveloxolone slows neurological progression in earlier-onset Friedreich’s ataxia

22 Jul 2024

Keto diet + exercise: Good for narcoleptics?

15 Jul 2024 by

A 10-week study presented at EAN 2024 has shown that a ketogenic or “keto” diet plus regular physical exercise may be beneficial for people with narcolepsy.